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Introduction
There is increasing recognition amongst health
service funders (Department of Health, 2000) and
prescribers (Royal College of Physicians, 1997) of
the growing amount and cost of prescribed medi-
cines that are unused or wasted. At the same time,
there is increasing evidence in developed coun-
tries that pharmaceutically active compounds leech
from land fill sites and from sewerage plants and
can enter the groundwater (Heberer, 2002). The
extent of unwanted medication has usually been
measured by pharmacists and costed by examining
returned waste in Dispose Unwanted Medicines
Properly (DUMP) campaigns, which invite patients
to return all unused medication to the pharmacy,
or in Brown Bag reviews, where patients are invited
to take all medication to a pharmacist for review
(Anon, 1992; Cromarty and Downie, 2001). The
General Pharmaceutical Services Bulletin for
England and Wales provides DUMP data by pri-
mary care trust (PCT) and health authority (HA)
for the year 2002/2003 (Department of Health,
2004). However, only 215 of the 342 PCTs in
England and five HA in Wales are able to pro-
vide data.
The purpose of this paper is first to review the
limited literature on medication waste and then to
draw on data produced during a repeat dispensing
pilot study which adds to our understanding of the
patients’ use of their medication (Wilson et al.,
2002). This study was one of 12 pilots that were
funded by the Department of Health through the
Community Pharmacists Wider Role Initiative in
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April 1997 to explore the pharmacist’s medicine
management role. At the same time we demon-
strate the potential for community pharmacists to
tackle the problems of waste National Health
Service (NHS) drugs resources.
Waste and unwanted medicines
In the UK, the National Pharmaceutical Associ-
ation (NPA) estimated the annual value of wasted
dispensed drugs at £37.6 million (Anon, 2000a)
compared with a total expenditure on drugs in
2002 of £6.8 billion (Department of Health, 2003).
Considerable publicity has been given to attempts
to reduce this. For example, Wiltshire Health
Authority mounted an education campaign after
noting that almost 2% of its £53 million drug
budget was being spent on medicines which are
never used and blame was attributed to patients
ordering multiple item repeat medications (Anon,
2000b).This is an international problem. In Sweden,
researchers who collected returned drugs from
100 pharmacies for one year calculated a mean of
17.3 tonnes per month of waste, but noted that the
unused medication was of relatively small cost
items (Ekedahl et al., 2003). In the UK, the gov-
ernment funded Disposal of Old Pharmaceuticals
(DOOP) scheme recorded a total collection of 609
tonnes from community pharmacies in the year
ending March 2002 (Department of Health, 2002).
However, these types of study only measure the
medication returned to pharmacies, there are no
data on medication returned to general practitioner
(GP) surgeries. In addition, there is qualitative evi-
dence that householders also rid themselves of
superfluous medications by disposal through the
municipal waste bin collection and by flushing to
the public sewerage system (Chartered Institute of
Wastes Management, 2000). A proper knowledge
of this hidden behaviour and its environmental
impact has yet to be developed and is not pursued
further here.
Explanations for waste
Failure in the repeat prescribing process is a
commonly held explanation for medicines waste.
A conference for health professionals on wasteful
prescribing was held in 2001 to discuss ways of
tackling the problem (Bellingham, 2001). In the
UK, problems with the management of the repeat
prescribing system are well documented (Davidson
et al., 1998; McGavock et al., 1999). These range
from the practical, where doctors are ‘exasperated
by an increasingly time consuming but otherwise
dull task’ (Drury, 1982) to clinical concerns about
the scale of long-term medication without proper
review (Harris and Dadja, 1996). Others assert that
many long-term medication reviews were actually
inadequate (Zermansky, 1996).Whatever the cause,
the impact on the patient can be drug stockpiling
and poor compliance (Audit Commission, 1994;
Bond, 2000).
The reasons why patients accumulate unused
medication are less well understood. One study in
West Yorkshire measured routinely returned drugs
to 33 pharmacies over one month and so derived 
a profile of the returned drugs in terms of both
value and British National Formulary (BNF) clas-
sification (Hawksworth et al., 1996).This study cat-
egorized reasons for the return of unwanted
medication to the pharmacy as: death (42.1%), too
much stock at home (23.4%), medication no longer
required because changed by prescriber (25%) and
medicines had passed expiry date (5.0%).The data
imply that 67% of waste is unavoidable. A later,
but similar, study based on four pharmacies in Wales
measured 10 weeks of returns and added three
more explanatory categories: medication stopped
by patient, adverse effect from drugs, error of pre-
scription, order or supply (Braybrook et al., 1999).
We contend that three of these seven reasons for
waste are clearly avoidable (see Table 1).
The limitation of both these studies is that they
tell us only what was returned and limited cat-
egorical reasons for the return. Neither study
sheds much light on how or why patients acquired
the medication in the first place.
Intervention to reduce waste
To date there have been three main approaches
to the problem of medicines waste. The first is
through patient education using health promotion
leaflets, DUMP campaigns and Brown Bag reviews.
For example, the UK Pharmaceutical Services
Negotiating Committee (PSNC) reports 17 DUMP
campaigns and drug waste management projects
undertaken since 1994 (Pharmaceutical Negotiating
Committee, 2003).The second is by attention to pre-
scribing, which can be seen as part of the wholesale
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review of prescribing management that has been
ongoing over the last 10 years. This has been
driven through increasing scrutiny by health ser-
vice managers with a primary focus upon achieving
better value for money through cost-effective 
prescribing (Davidson et al., 1997; Staunton, 1997).
An increasing number of studies detail the contri-
bution of pharmacists working in primary care with
GPs to improve prescribing practice and enhance
patient care (Sykes et al., 1996; Davidson et al.,
1997; Goldstein et al., 1997; Wood et al., 1997;
Burtonwood et al., 1998;Dowell et al., 1998;Geoghan
et al., 1998; Petty et al., 2002). The third is through
engagement of patients in their health care.
Compliance is a description of patient behaviour in
which patients are expected to take medicines as
instructed. The more recent approach of concor-
dance involves a process in which patient and pre-
scriber reach agreement on medication in the
expectation that engagement of the patient in the
decision will lead to improved adherence (Royal
Pharmaceutical Society, 1997).
Better repeat prescribing as a means to cut waste
An impressive number of studies have detailed
the outcome of medication reviews in the medical
practice, which offer insight into ways of meas-
uring and reducing the amount of unwanted medi-
cines. Many of the early reviews concentrated on
improving the standard of prescribing by examin-
ing prescribing analysis costs (PACT) data, acting
on proprietary and generic substitution, switching
expensive for cheaper alternatives and identify-
ing ineffective drugs for the indication stated.
Following this initial focus, prescribing support
pharmacists have moved on to tackle other repeat
prescribing issues, including waste. The three most
common problems identified on GP notes and
patient record systems were inappropriate direc-
tions, inconsistent quantities and drugs no longer
required. It has been suggested that greater atten-
tion to reviewing medication ordered on a repeat
basis could greatly reduce drug costs (Goldstein 
et al., 1997) and by implication waste. The success
of these prescribing initiatives was recognized
through government policy, funding and support
for every PCT from the National Collaborative
Medicines Management services programme. Key
aims were to identify and address unmet pharma-
ceutical need, to help patients to get the best out of
their medicines and develop approaches which
improve service efficiency and reduce waste
(Jackson et al., 2002). Moreover, the National
Service Framework for Older People (NSFOP)
specified that all patients over 75 should normally
have an annual review of their medication (Depart-
ment of Health, 2001).
In comparison, we know less about outcomes
when review takes place in the community phar-
macy, where the patient case notes and prescribing
history is not necessarily available. The repeat dis-
pensing pilot study contributes to this part of the
debate.
Methods
The repeat dispensing pilot study
The policy context of the repeat dispensing pilot
was the engagement of pharmacists in patient-
centred care to achieve better health outcomes
through improved prescribing coupled with a
reduction in waste (Audit Commission, 1994). The
Table 1 Reason for returning wasted medication and the extent to which they are avoidable
Category Scope for reduction
Death Unavoidable, amenable to closer monitoring
Medication no longer required because changed by prescriber Unavoidable
Too much stock at home Avoidable
Medicines had passed expiry date Avoidable (depends on drug)
Medication stopped by patient Unavoidable
Adverse effect from drugs Unavoidable
Error of prescription, order or supply Avoidable
Source: Hawksworth et al., 1996; Braybrook et al., 1999.
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Birmingham repeat dispensing pilot study allowed
community pharmacists to dispense repeat medi-
cation without the need for the patient to visit the
surgery. One objective was to make a measurable
change in prescribed medicines with a calculated
reduction in medicines wastage, whilst at the same
time achieving improved standards of pharmaceut-
ical care. The study was based in two medical prac-
tices and seven community pharmacies within the
West Midlands conurbation. Neither practice had
undertaken a systematic clinical medication review
of patients on repeat prescriptions.A more detailed
description of this pilot study has been reported
elsewhere (Wilson et al., 2002).
Sample selection
Experience elsewhere showed that inviting
patients to voluntarily attend a community phar-
macy for a review of their medication was not well
taken up (Nathan et al., 1999). To overcome this
problem, the patient sample was drawn using a
four-stage strategy. Initial identification of poten-
tial patients was by prescriptions issued by the two
practices and presented at the study pharmacies.
The pharmacists checked their records to confirm
repeat status and then the names were screened 
by the medical practitioners for deletion of any
patient deemed clinically unsuitable. This group
was invited by post to participate in the study.
From a total of 618 repeat patients who agreed to
participate, a sub-sample of 350 was enrolled into
the intervention, distributed across seven pharma-
cies.Thus the patients were volunteers, selected on
the basis of repeat medication prescribed and dis-
pensed by the participating organizations. The
intention was to work with a typical cross-section
of patients, not to select by specified clinical or
therapeutic criteria.
The study intervention
Patients were entered for six months using 
prescriptions issued by the practices for all medi-
cation authorized for repeat prescribing by the
supervising GP. Two local research ethics commit-
tees approved the project design and instruments.
The intention was to allow dispensing pharmacists
to take a greater part in working with patients in
the management of their medication. There was
flexibility in the pharmacist’s ability to become
involved in the choice as to whether a) it was appro-
priate to dispense an individual item, and b) what
quantity was required. Participating pharmacists
were remunerated on a patient per capita basis
rather than the normal method which is based
upon a fee for each item dispensed. The intention
was to remove any disincentive not to supply and
to provide some additional payment to recom-
pense for the extra pharmaceutical care provided in
the project. Monitoring systems included patient–
pharmacist monitoring forms to record activity
with duplicate pads of referral forms to allow com-
munication back to the GP, while GPs had forms
to notify medication changes to the pharmacist. It
is the monitoring forms which provide the evi-
dence for the findings described in the following
section. In addition to identifier detail, the phar-
macy monitoring form provided information on
six elements: the number of items not dispensed;
whether there were any issues of interactions, side
effects, adverse drug reactions (ADR), compli-
ance or any other drug related concerns; details of
any problems discussed; whether a referral was
made; details of any supply issues; who collected
the medication; consultation time.
Results
Study sample
The demographic profile of the selected sub-
sample was: 62% female, 38% male; 89% white,
7% black Caribbean, 5% Asian.The age range was
predominantly elderly, 8% under 42, 25% were
43–62, 67% over 62. Eighty-eight per cent were
exempt from payment, 5% had a prepayment cer-
tificate; 66% of participants had up to four repeat
items, 14% six or more items. Seventy-five per cent
had been on repeat medication for more than two
years. The health professionals involved con-
sidered this to be a good cross-section of patients
receiving repeat medication.
Study findings: the prescription data
At each ordering of medication, the pharmacists
completed a patient monitoring form, entering
details about the medication dispensed and free
text on issues which arose during the consultation.
A total of 167 free text entries were made. A total
of 288 patients completed the full six months of
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the study and these patients had available to them
a total of 1501 different medicines, each available
for multiple supply. A total of 7153 supplies could
have been made during the six months of the pro-
ject, of which 5454 were actually dispensed.
Therefore 23.8% of the potential supplies were
not made representing an ingredient value of
£13.1K. A detailed analysis of the cost savings 
of the Birmingham pilot study have been reported
elsewhere (Wilson and Jesson, 2003). This reflects
potential waste if the project had not been running.
Each medicine was categorized as either essen-
tial for a chronic condition, which should be taken
continuously, or as symptomatic relief to be taken
in accordance with patient needs and therefore not
necessarily continuously. We would expect medi-
cines for chronic conditions to be collected regu-
larly and medicines for symptomatic relief to be
collected according to patient need.A total of 62%
of the prescribed medicines were for chronic con-
ditions. This means that 38% of the prescribed
medicines would not necessarily be taken regularly
and therefore if supplied regularly might generate
waste. It is within this group that there is potential
for saving, if patients are supported in their deci-
sion concerning supply (Wilson and Jesson, 2003).
The pharmacist recorded each consultation and
this showed how spending time discussing medica-
tion needs with the patient helps them to make a
better choice each month when they decide which
medication to collect. These records also demon-
strated the increased difficulties when medication
is collected by a carer or patient representative
since these intermediaries frequently did not 
have an informed appreciation of the medication
required.
Analysis
The free comments were typed up, coded by
pharmacy and patient number. Using grounded
analysis the selected data were searched for com-
mon patterns by a process of highlighting. Then
each set of highlighted responses were re-allocated
into themes (Easterby-Smith et al., 2002). This
process was undertaken independently by two
researchers until consensus was reached on labelling
five categories: over-collection in the past, self-
management strategies, changes in medical condi-
tion, other changes in patient circumstances, repeat
medicines policy administration at the surgery.The
features of each category are summarized below,
with examples to support the analysis.
 Over-collection in the past: This selection of
comments made by the pharmacist at the point
of supply shows that patients did need some reg-
ular help in ordering and managing the collection
of their medication. The drugs referred to by the
pharmacist are mainly analgesics, but others were
involved.
First collection. Apparently had plenty left
at home over past three months.
Plenty of Co-dydramol left from last time
so not dispensed. Patient checked back and
also has plenty frusemide left so again not
dispensed.
Patient was going to order Dihydrocodeine
but on talking to her she discovered she had
plenty left.
 Self-management: Some patients were trying to
manage their own care by adapting their medi-
cation to suit their own illness patterns, lifestyle
and health needs. With help from the pharmacist
in managing their medicines, that particular form
of self-care can be supported and encouraged,
but monitored in a friendly but informative way.
Since the medical practices did not monitor usage
of medicines, this support by a pharmacist was an
additional service not currently provided.
Only take half a tablet of the 1 mg Warfarin,
so only 14 dispensed.
Doesn’t take full quantity of co-codamol so
gave half.
 Changes in medical condition: It is inevitable
that in patients with chronic conditions their
medication profile will change over time, some-
times changes are made from secondary care, as
the following comments illustrate.
Hands have cleared up since stopped work,
so mexosyn and co-proxamol rarely used
now as not required.
No angina attacks recently – still got plenty
of unopened GTN tabs.
Patient has been in hospital so has not 
used her last medication, barring the 
paracetamol – so nothing else dispensed.
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 Repeat medicines policy administration at sur-
gery end: This fifth category covers the medicines
management procedures at the surgery where
effective repeat medication management systems
should pick up items no longer prescribed or
needed.
No longer taking one set of medication.
Taken off by GP but still on script.
The study identified a number of examples where
medicine management discussions with patients 
in the pharmacy lead to more cost-effective use 
of NHS resources. Three-quarters of patients col-
lected their own medication, supporting other
study findings. However, the 25% who collected
for another emerged as the group where the likeli-
hood for confusion over quantities of medication
needed was more pronounced and therefore as the
group who probably need most support and time
investment. The comments written by pharmacists
illustrate the need for direct access to the patient,
whether by domiciliary visit or by telephone. The
following examples of discussion between pharma-
cists and patient representatives illustrates the type
of issues that can arise when the patient is not
present.
Son came to collect medication – did not
know which items were required, therefore I
phoned the patient at home.
Patient was using nitrolingual spray up to 
10 times daily according to daughter, even
though not experiencing any pains in chest.
Have filled in GP referral form.
Sends a representative who doesn’t know
what patient needs. Just says give everything –
sent him back to ask patient what he really
needs.
Discussion
This six-month pilot study allowed dispensing
pharmacists to check and document the collection
and use of medications on repeat prescriptions
and gave us insight into the problem of accumulat-
ing unused medicine. In quantitative terms we
have shown that just under a quarter of the pre-
scribed items were not collected and this indicates
the potential for a repeat dispensing service to
reduce medication waste. However, the study also
shows that the process of repeat medication sup-
ply is complex.The patients in our study had avail-
able to them an average of over five medications
each month and these included those for chronic
ongoing conditions where continuous, regular
therapy is essential and those for variable condi-
tions that the patient has to manage according to
symptoms.
Our study adds to the debate on waste medi-
cines, by providing more than quantitative data on
waste, we demonstrate that a better professional
understanding and involvement at each point of
supply can benefit individual patients care and at the
same time reduce the potential for unwanted sup-
ply. This finding has been recognized in the design
of the PCT Pathfinder Repeat Dispensing project
which commenced in 2003. Repeat Dispensing
Services can also complement other PCT require-
ments of the NSFOP and the Medicines Manage-
ment Collaborative reviews, which are undertaken
periodically at the point of prescribing.
The limitations of the study are the size and
scope of a pilot study. Nonetheless the quantita-
tive data on nondispensed medication is similar 
to findings from other repeat dispensing studies
(Wilson and Jesson, 2003) and therefore fairly
robust. It was the additional qualitative data
recorded by pharmacists that offered us a chance
to explore, using a grounded inductive approach,
the reasons that patients gave for not needing
their next prescription dispensed. By comparison,
other studies on returned waste used precoded
categories to record reasons for returning unused
medication.
Debates about the amount and cost of unused
medication returned for disposal summarized in
the literature review above, have caused consider-
able concern at the waste of resources, cost to the
NHS and the cost of disposal and potential dam-
age to the environment. Interventions to date have
focused on four approaches: publicity to cut down
on waste through Brown Bag reviews, health pro-
motion leaflets, DUMP campaigns and attempts to
achieve better compliance (concordance). Many
studies have shown that it is possible to achieve
change through clinical review.The changes can be
made periodically at the point of prescribing at the
surgery or regularly at the point of supply at the
pharmacy. This study was based at the final point
in the supply cycle, that of dispensing when there
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is the potential for direct contact between the
patient and a health professional.As our data show,
there can be a change in circumstances which may
not automatically be picked up at the issue of repeat
medication prescription.
The findings from this study emphasize the com-
plexity of the decision process on medication
needs, which requires knowledge of both the 
function of the medication and the underlying
medical condition. Even during this pilot there
was a mismatch between regularity of supply and
the nature of the medication and there were a
number of medications for chronic conditions that
were not regularly supplied. However, it is import-
ant to recognize that the decision as to whether 
a medication was needed lay with the patient or
their representative. Our study reinforces the need
for patient guidance in this decision process and
therefore the potential for professional support.
In the past there has been an emphasis on 
measuring waste by volume, and for developing a
theory about the causes of waste that had a 
tendency to blame the patient through assumption
of noncompliance with prescribing directions.
Theoretically an approach to prescribing based
upon ‘concordance’ might be expected to reduce
medicines waste (Royal Pharmaceutical Society,
1997), however, the evidence from earlier studies
(Table 1) shows that many of the reasons given by
patients for returning unwanted drugs are
unavoidable, such as ‘death of the patient’, ‘no
longer required, changed by prescriber’ and
‘stopped by a patient experiencing ADR’. Others
are avoidable and these include patient related
issues such as ‘too much stored’, passed expiry
date and problems relating to the prescribing
process such as errors in prescription ordering.
The analysis of qualitative comments from the
study confirm that many instances are avoidable:
we have added some of the contextual back-
ground to demonstrate reasons, for example, why
‘too much is stored’.
There has been increasing recognition of the
importance of the prescribing process but this is
inevitably remote from the patient with only peri-
odic review between prescriber and patient. In this
study, we have focussed upon the point of supply
within the community pharmacy. By drawing on
the pharmacist’s comments at the point of supply
we have greater insight into the supply side and
patient behaviour. We believe that this indicates a
need for better professional support. Optimizing
supply must be a partnership process that involves
prescriber, supplier and patient and the repeat dis-
pensing process that we have described embraces
all three elements. It provides a method of waste
minimization, but more importantly, a support
process for patient decisions on long-term medica-
tion needs.
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